CONMED Corp (CNMD)
Sector: Electromedical & Electrotherapeutic Apparatus
Industry: Medical - Devices
CONMED Corporation
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 9, 2026 | 52.05 | 52.76 | 51.19 | 51.94 | 375,677 |
| Nov 6, 2026 | 51.11 | 52.39 | 51.11 | 51.50 | 331,564 |
| Nov 5, 2026 | 54.40 | 54.80 | 51.70 | 52.83 | 406,922 |
| Nov 4, 2026 | 47.99 | 53.73 | 47.99 | 53.66 | 592,355 |
| Nov 3, 2026 | 46.71 | 47.79 | 46.25 | 47.23 | 510,103 |
| Nov 2, 2026 | 44.76 | 47.24 | 44.76 | 46.59 | 444,226 |
| Oct 30, 2026 | 45.71 | 46.33 | 43.67 | 44.29 | 404,078 |
| Oct 29, 2026 | 43.60 | 46.47 | 43.50 | 45.72 | 482,189 |
| Oct 28, 2026 | 47.40 | 48.09 | 45.12 | 45.76 | 610,185 |
| Oct 27, 2026 | 48.09 | 48.09 | 46.53 | 47.20 | 505,948 |
| Oct 26, 2026 | 48.78 | 49.73 | 47.56 | 47.68 | 386,605 |
| Oct 23, 2026 | 49.03 | 49.72 | 48.31 | 49.25 | 343,265 |
| Oct 22, 2026 | 47.38 | 49.56 | 47.38 | 49.44 | 398,584 |
| Oct 21, 2026 | 46.92 | 47.80 | 46.54 | 47.11 | 442,963 |
| Oct 20, 2026 | 45.81 | 48.00 | 45.81 | 47.58 | 440,153 |
| Oct 19, 2026 | 46.49 | 47.06 | 45.89 | 46.05 | 342,341 |
| Oct 16, 2026 | 47.32 | 47.80 | 46.50 | 46.72 | 413,968 |
| Oct 15, 2026 | 45.59 | 47.85 | 44.89 | 47.14 | 401,286 |
| Oct 14, 2026 | 45.23 | 46.59 | 44.53 | 44.93 | 392,390 |
| Oct 13, 2026 | 45.59 | 46.09 | 44.09 | 45.55 | 521,744 |
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| General Counsel & Corp Sec | Option Exercise | 4.0K | -- | Nov 4, 2026 | |
| General Counsel & Corp Sec | Automatic Sell | 1.1K | $60.3K | Nov 4, 2026 | |
| General Counsel & Corp Sec | Option Exercise | 4.0K | -- | Nov 4, 2026 | |
| Director | Option Exercise | 500 | -- | Sep 8, 2026 | |
| Director | Option Exercise | 500 | -- | Sep 8, 2026 | |
| Executive Vice President & CFO | Grant/Award | 35.1K | -- | Jul 15, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
BlackRock, Inc. | 4.8M | 16.2% | 13F |
BlackRock, Inc. · also on 13F· may incl. warrants· filed Jul 2025 | 4.7M | 15.7% | 13G |
EARNEST PARTNERS LLC | 2.5M | 8.4% | 13F |
VANGUARD PORTFOLIO MANAGEMENT LLC | 2.2M | 7.3% | 13F |
FULLER & THALER ASSET MANAGEMENT, INC. | 1.6M | 5.3% | 13F |
DIMENSIONAL FUND ADVISORS LP | 1.5M | 4.9% | 13F |
STATE STREET CORP | 1.4M | 4.8% | 13F |
VANGUARD CAPITAL MANAGEMENT LLC | 1.4M | 4.5% | 13F |
BANK OF AMERICA CORP /DE/ | 1.3M | 4.5% | 13F |
SEI INVESTMENTS CO | 988.2K | 3.3% | 13F |
Insiders
- Foust Hollie KGeneral Counsel & Corp Sec
- Kelderman KimDirector
- Gallagher John EExecutive Vice President & CFO
- Martin Celine ChristineDirector
- Mirviss Jeffrey B.Director
- Farkas CharlesDirector
- Schwarzentraub Barbara JDirector
- Kaye MarkDirector
- Council LaVerne HDirector
- Bronson David M.Director
CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures.
Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors. These innovative offerings provide unique clinical advantages to orthopedic surgeons for repairing soft tissue injuries and are complemented by supportive tools that facilitate minimally invasive sports medicine operations. These orthopedic solutions are marketed under prominent brand names, including Hall, CONMED Linvatec, Concept, and Shutt. Furthermore, CONMED supplies general surgical equipment, encompassing items for clinical insufflation, smoke evacuation, electrosurgical interventions, and endomechanical applications.
Its endoscopic technology segment provides both diagnostic and therapeutic instruments utilized in gastroenterological procedures, alongside products specifically designed for addressing conditions of the biliary system.
The company also offers cardiac monitoring solutions, featuring ECG and EEG electrodes, and pads for cardiac defibrillation. CONMED distributes its diverse range of products directly to a wide array of healthcare facilities, including hospitals and surgical centers, and also leverages specialized medical distributors. Established in 1970, CONMED Corporation maintains its corporate headquarters in Largo, Florida.
13F filers report 33.27M shares, more than the 29.80M outstanding, so no percentage is shown. 13F reports lag by a quarter and shares lent to short sellers can be counted twice.
30d Avg
441.04K
60d Avg
405.96K
90d Avg
369.42K